Leukocidins: Staphylococcal bi-component pore-forming toxins find their receptors

Nature Reviews Microbiology

Volumn 15, Issue 7, 2017, Pages 435-447

  Spaan, András N ^a   Van Strijp, Jos A G ^a   Torres, Victor J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCIDIN; LEUKOCIDIN RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CYTOTOXIN; VIRULENCE FACTOR;

CELL DEATH; GENE EXPRESSION; GENOMICS; HOST CELL; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; PHYSIOLOGY; TROPISM;

CYTOTOXINS; HUMANS; LEUKOCIDINS; RECEPTORS, CELL SURFACE; STAPHYLOCOCCUS AUREUS; TROPISM; VIRULENCE FACTORS;

EID: 85017600427     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.27     Document Type: Review

References (126)

1. Lowy, F. D. Staphylococcus aureus infections. N. Engl. J. Med. 339, 520-532 (1998).
2. Thwaites, G. E. et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect. Dis. 11, 208-222 (2011).
3. Deleo, F. R., Otto, M., Kreiswirth, B. N. & Chambers, H. F. Community associated meticillin resistant Staphylococcus aureus. Lancet 375, 1557-1568 (2010).
4. Thammavongsa, V., Kim, H. K., Missiakas, D. & Schneewind, O. Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13, 529-543 (2015).
5. Hammer, N. D. & Skaar, E. P. Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu. Rev. Microbiol. 65, 129-147 (2011).
6. Skaar, E. P., Humayun, M., Bae, T., DeBord, K. L. & Schneewind, O. Iron source preference of Staphylococcus aureus infections. Science 305, 1626-1628 (2004).
7. Alonzo, F. III & Torres, V. J. The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol. Mol. Biol. Rev. 78, 199-230 (2014).
8. Peschel, A. & Otto, M. Phenol soluble modulins and staphylococcal infection. Nat. Rev. Microbiol. 11, 667-673 (2013).
9. Spaan, A. N., Surewaard, B. G., Nijland, R. & van Strijp, J. A. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu. Rev. Microbiol. 67, 629-650 (2013).
10. Alonzo, F. III et al. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493, 51-55 (2013).
11. Vandenesch, F., Lina, G. & Henry, T. Staphylococcus aureus hemolysins, bi component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol. 2, 12 (2012).
12. Panton, P. N. & Valentine, F. C. O. Staphylococcal toxin. Lancet 219, 506-508 (1932).
13. Berube, B. J. & Bubeck Wardenburg, J. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) 5, 1140-1166 (2013).
14. Peraro, M. D. & van der Goot, F. G. Pore-forming toxins: ancient, but never really out of fashion. Nat. Rev. Microbiol. 14, 77-92 (2016).
15. Prevost, G., Bouakham, T., Piemont, Y. & Monteil, H. Characterisation of a synergohymenotropic toxin produced by Staphylococcus intermedius. FEBS Lett. 376, 135-140 (1995).
16. Koop, G. et al. Identification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus. Sci. Rep. 7, 40660 (2017).
17. Loffler, B. et al. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6, e1000715 (2010).
18. Yamashita, K. et al. Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components. Proc. Natl Acad. Sci. USA 108, 17314-17319 (2011).
19. DuMont, A. L. et al. Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition. Infect. Immun. 82, 1268-1276 (2014).
20. Yamashita, D. et al. Molecular basis of transmembrane β-barrel formation of staphylococcal pore-forming toxins. Nat. Commun. 5, 4897 (2014).
21. Badarau, A. et al. Structure-function analysis of heterodimer formation, oligomerization, and receptor binding of the Staphylococcus aureus bi component toxin LukGH. J. Biol. Chem. 290, 142-156 (2015).
22. Badarau, A. et al. Context matters: the importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies. mAbs 8, 1347-1360 (2016).
23. Sugawara-Tomita, N., Tomita, T. & Kamio, Y. Stochastic assembly of two-component staphylococcal γ-hemolysin into heteroheptameric transmembrane pores with alternate subunit arrangements in ratios of 3:4 and 4:3. J. Bacteriol. 184, 4747-4756 (2002).
24. Das, S. K., Darshi, M., Cheley, S., Wallace, M. I. & Bayley, H. Membrane protein stoichiometry determined from the step wise photobleaching of dye-labelled subunits. Chembiochem 8, 994-999 (2007).
25. Colin, D. A., Mazurier, I., Sire, S. & Finck-Barbancon, V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect. Immun. 62, 3184-3188 (1994).
26. Meunier, O. et al. A predicted β-sheet from class S components of staphylococcal γ-hemolysin is essential for the secondary interaction of the class F component. Biochim. Biophys. Acta 1326, 275-286 (1997).
27. Gauduchon, V., Werner, S., Prevost, G., Monteil, H. & Colin, D. A. Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect. Immun. 69, 2390-2395 (2001).
28. Meyer, F., Girardot, R., Piemont, Y., Prevost, G. & Colin, D. A. Analysis of the specificity of Panton-Valentine leucocidin and γ-hemolysin F component binding. Infect. Immun. 77, 266-273 (2009).
29. Ozawa, T., Kaneko, J. & Kamio, Y. Essential binding of LukF of staphylococcal γ-hemolysin followed by the binding of HγII for the hemolysis of human erythrocytes. Biosci. Biotechnol. Biochem. 59, 1181-1183 (1995).
30. Kaneko, J., Ozawa, T., Tomita, T. & Kamio, Y. Sequential binding of staphylococcal γ-hemolysin to human erythrocytes and complex formation of the hemolysin on the cell surface. Biosci. Biotechnol. Biochem. 61, 846-851 (1997).
31. Ferreras, M. et al. The interaction of Staphylococcus aureus bi component γ-hemolysins and leucocidins with cells and lipid membranes. Biochim. Biophys. Acta 1414, 108-126 (1998).
32. Morinaga, N., Kaihou, Y. & Noda, M. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi component leukotoxin family. Microbiol. Immunol. 47, 81-90 (2003).
33. Reyes-Robles, T., Lubkin, A., Alonzo, F. III, Lacy, D. B. & Torres, V. J. Exploiting dominant negative toxins to combat Staphylococcus aureus pathogenesis. EMBO Rep. 17, 428-440 (2016).
34. Spaan, A. N. et al. The staphylococcal toxin Panton-Valentine leukocidin targets human C5a receptors. Cell Host Microbe 13, 584-594 (2013).
35. Reyes-Robles, T. et al. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14, 453-459 (2013).
36. Spaan, A. N. et al. The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat. Commun. 5, 5438 (2014).
37. DuMont, A. L. et al. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac 1. Proc. Natl Acad. Sci. USA 110, 10794-10799 (2013).
38. Spaan, A. N. et al. Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes. Cell Host Microbe 18, 363-370 (2015).
39. Vrieling, M. et al. Bovine Staphylococcus aureus secretes the leukocidin LukMF' to kill migrating neutrophils through CCR1. mBio 6, e00335 (2015).
40. Venkatakrishnan, A. J. et al. Molecular signatures of G protein-coupled receptors. Nature 494, 185-194 (2013).
41. Tournamille, C., Colin, Y., Cartron, J. P. & Le Van Kim, C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10, 224-228 (1995).
42. Pruenster, M. & Rot, A. Throwing light on DARC. Biochem. Soc. Trans. 34, 1005-1008 (2006).
43. Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002).
44. Yoong, P. & Torres, V. J. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr. Opin. Microbiol. 16, 63-69 (2013).
45. Tam, K. et al. Staphylococcus aureus leukocidin LukED and HIV 1 gp120 target different sequence determinants on CCR5. mBio 7, e02024 16 (2016).
46. Laventie, B. J. et al. Residues essential for Panton-Valentine leukocidin S component binding to its cell receptor suggest both plasticity and adaptability in its interaction surface. PLoS ONE 9, e92094 (2014).
47. Spaan, A. N. et al. Differential interaction of the staphylococcal toxins Panton-Valentine leukocidin and γ-hemolysin CB with human C5a receptors. J. Immunol. 195, 1034-1043 (2015).
48. Koymans, K. J., Vrieling, M., Gorham, R. D. Jr & van Strijp, J. A. Staphylococcal immune evasion proteins: structure, function, and host adaptation. Curr. Top. Microbiol. Immunol. http://dx.doi.org/10.1007/82-2015-5017 (2016).
49. Prevost, G. et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J. Med. Microbiol. 42, 237-245 (1995).
50. von Eiff, C., Friedrich, A. W., Peters, G. & Becker, K. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 49, 157-162 (2004).
51. Kaneko, J., Kimura, T., Narita, S., Tomita, T. & Kamio, Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage φPVL carrying Panton-Valentine leukocidin genes. Gene 215, 57-67 (1998).
52. Naimi, T. S. et al. Comparison of community-and health care associated methicillin resistant Staphylococcus aureus infection. JAMA 290, 2976-2984 (2003).
53. Baba, T. et al. Complete genome sequence of Macrococcus caseolyticus strain JCSCS5402, reflecting the ancestral genome of the human-pathogenic staphylococci. J. Bacteriol. 191, 1180-1190 (2009).
54. Cooney, J., Kienle, Z., Foster, T. J. & O'Toole, P. W. The γ-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect. Immun. 61, 768-771 (1993).
55. Novick, R. P. & Geisinger, E. Quorum sensing in staphylococci. Annu. Rev. Genet. 42, 541-564 (2008).
56. Dunman, P. M. et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183, 7341-7353 (2001).
57. Benson, M. A. et al. Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element. Mol. Microbiol. 93, 664-681 (2014).
58. Flack, C. E. et al. Differential regulation of staphylococcal virulence by the sensor kinase SaeS in response to neutrophil derived stimuli. Proc. Natl Acad. Sci. USA 111, E2037-E2045 (2014).
59. Zurek, O. W. et al. The role of innate immunity in promoting SaeR/S mediated virulence in Staphylococcus aureus. J. Innate Immun. 6, 21-30 (2014).
60. Voyich, J. M. et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 175, 3907-3919 (2005).
61. Voyich, J. M. et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J. Infect. Dis. 199, 1698-1706 (2009).
62. Malachowa, N. et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 6, e18617 (2011).
63. DuMont, A. L. et al. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect. Immun. 81, 1830-1841 (2013).
64. Balasubramanian, D. et al. Staphylococcus aureus coordinates leukocidin expression and pathogenesis by sensing metabolic fluxes via RpiRc. mBio 7, e00818 16 (2016).
65. Dumont, A. L. et al. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79, 814-825 (2011).
66. Ventura, C. L. et al. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE 5, e11634 (2010).
67. Badiou, C. et al. Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme linked immunosorbent assay and immunochromatographic tests. J. Clin. Microbiol. 48, 1384-1390 (2010).
68. Attia, A. S. et al. Analysis of the Staphylococcus aureus abscess proteome identifies antimicrobial host proteins and bacterial stress responses at the host-pathogen interface. Pathog. Dis. 69, 36-48 (2013).
69. Date, S. V. et al. Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. J. Infect. Dis. 209, 1542-1550 (2014).
70. Thomsen, I. P. et al. Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB. Infect. Immun. 82, 1234-1242 (2014).
71. Adhikari, R. P. et al. Antibodies to S. aureus LukS-PV attenuated subunit vaccine neutralize a broad spectrum of canonical and non-canonical bicomponent leukotoxin pairs. PLoS ONE 10, e0137874 (2015).
72. Wilke, G. A. & Bubeck Wardenburg, J. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc. Natl Acad. Sci. USA 107, 13473-13478 (2010).
73. Davis, B., Wen, H. & Ting, J. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29, 707-735 (2011).
74. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
75. Holzinger, D. et al. Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J. Leukoc. Biol. 92, 1069-1081 (2012).
76. Melehani, J. H., James, D. B., DuMont, A. L., Torres, V. J. & Duncan, J. A. Staphylococcus aureus leukocidin A/B (LukAB) kills human monocytes via host NLRP3 and ASC when extracellular, but not intracellular. PLoS Pathog. 11, e1004970 (2015).
77. Munoz-Planillo, R., Franchi, L., Miller, L. S. & Nunez, G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J. Immunol. 183, 3942-3948 (2009).
78. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142-1153 (2013).
79. Perret, M. et al. Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cell. Microbiol. 14, 1019-1036 (2012).
80. Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665 (2015).
81. Kayagaki, N. et al. Caspase 11 cleaves gasdermin D for non canonical inflammasome signalling. Nature 526, 666-671 (2015).
82. Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111-116 (2016).
83. Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153-158 (2016).
84. He, W. T. et al. Gasdermin D is an executor of pyroptosis and required for interleukin 1β secretion. Cell Res. 25, 1285-1298 (2015).
85. Graves, S. F. et al. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J. Leukoc. Biol. 92, 361-374 (2012).
86. Malachowa, N., Kobayashi, S. D., Freedman, B., Dorward, D. W. & DeLeo, F. R. Staphylococcus aureus leukotoxin GH promotes formation of neutrophil extracellular traps. J. Immunol. 191, 6022-6029 (2013).
87. Yoong, P. & Torres, V. J. Counter inhibition between leukotoxins attenuates Staphylococcus aureus virulence. Nat. Commun. 6, 8125 (2015).
88. Torres, V. J. et al. Staphylococcus aureus Fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect. Immun. 78, 1618-1628 (2010).
89. Torres, V. J., Pishchany, G., Humayun, M., Schneewind, O. & Skaar, E. P. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J. Bacteriol. 188, 8421-8429 (2006).
90. Hongo, I. et al. Phenol-soluble modulin α3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J. Infect. Dis. 200, 715-723 (2009).
91. Munzenmayer, L. et al. Influence of Sae regulated and Agr-regulated factors on the escape of Staphylococcus aureus from human macrophages. Cell. Microbiol. 18, 1172-1183 (2016).
92. Nilsson, I. M., Hartford, O., Foster, T. & Tarkowski, A. α-Toxin and γ-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect. Immun. 67, 1045-1049 (1999).
93. Supersac, G., Piemont, Y., Kubina, M., Prevost, G. & Foster, T. J. Assessment of the role of γ-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb. Pathog. 24, 241-251 (1998).
94. Scherr, T. D. et al. Staphylococcus aureus biofilms induce macrophage dysfunction through leukocidin AB and alpha-toxin. mBio 6, e01021 15 (2015).
95. Voyich, J. M. et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194, 1761-1770 (2006).
96. Bubeck Wardenburg, J., Palazzolo Ballance, A. M., Otto, M., Schneewind, O. & DeLeo, F. R. Panton-Valentine leukocidin is not a virulence determinant in murine models of community associated methicillin resistant Staphylococcus aureus disease. J. Infect. Dis. 198, 1166-1170 (2008).
97. Yoong, P. & Pier, G. B. Antibody-mediated enhancement of community acquired methicillin resistant Staphylococcus aureus infection. Proc. Natl Acad. Sci. USA 107, 2241-2246 (2010).
98. Kobayashi, S. D. et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204, 937-941 (2011).
99. Malachowa, N. et al. Staphylococcus aureus leukotoxin GH promotes inflammation. J. Infect. Dis. 206, 1185-1193 (2012).
100. Aman, M. J. & Adhikari, R. P. Staphylococcal bicomponent pore forming toxins: targets for prophylaxis and immunotherapy. Toxins (Basel) 6, 950-972 (2014).
101. Sause, W. E., Buckley, P. T., Strohl, W. R., Lynch, A. S. & Torres, V. J. Antibody based biologics and their promise to combat Staphylococcus aureus infections. Trends Pharmacol. Sci. 37, 231-241 (2016).
102. Laventie, B. J. et al. Heavy chain only antibodies and tetravalent bispecific antibody neutralizing Staphylococcus aureus leukotoxins. Proc. Natl Acad. Sci. USA 108, 16404-16409 (2011).
103. Rouha, H. et al. Five birds, one stone: neutralization of α-hemolysin and 4 bi component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. mAbs 7, 243-254 (2015).
104. Diep, B. A. et al. Improved protection in a rabbit model of community associated methicillin resistant Staphylococcus aureus necrotizing pneumonia upon neutralization of leukocidins in addition to α-hemolysin. Antimicrob. Agents Chemother. 60, 6333-6340 (2016).
105. Thomsen, I. P. et al. Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB (LukAB) isolated following invasive human infection reveal diverse binding and modes of action. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jix071 (2017).
106. Verkaik, N. J. et al. Immunogenicity of toxins during Staphylococcus aureus infection. Clin. Infect. Dis. 50, 61-68 (2010).
107. Adhikari, R. P. et al. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J. Infect. Dis. 206, 915-923 (2012).
108. Hermos, C. R., Yoong, P. & Pier, G. B. High levels of antibody to Panton-Valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft tissue infection. Clin. Infect. Dis. 51, 1138-1146 (2010).
109. Brown, E. L. et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin. Microbiol. Infect. 15, 156-164 (2009).
110. Karauzum, H. et al. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. PLoS ONE 8, e65384 (2013).
111. Salgado-Pabon, W. & Schlievert, P. M. Models matter: the search for an effective Staphylococcus aureus vaccine. Nat. Rev. Microbiol. 12, 585-591 (2014).
112. Proctor, R. A. Is there a future for a Staphylococcus aureus vaccine? Vaccine 30, 2921-2927 (2012).
113. Tseng, C. W. et al. Increased susceptibility of humanized NSG mice to Panton-Valentine leukocidin and Staphylococcus aureus skin infection. PLoS Pathog. 11, e1005292 (2015).
114. Prince, A., Wang, H., Kitur, K. & Parker, D. Humanized mice exhibit increased susceptibility to Staphylococcus aureus pneumonia. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jiw425 (2016).
115. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370-1379 (2013).
116. Alonzo, F. III et al. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol. Microbiol. 83, 423-435 (2012).
117. Lek, M. et al. Analysis of protein coding genetic variation in 60,706 humans. Nature 536, 285-291 (2016).
118. Fitzgerald, J. R. Livestock-associated Staphylococcus aureus: origin, evolution and public health threat. Trends Microbiol. 20, 192-198 (2012).
119. Vrieling, M. et al. LukMF' is the major secreted leukocidin of bovine Staphylococcus aureus and is produced in vivo during bovine mastitis. Sci. Rep. 6, 37759 (2016).
120. Woolhouse, M. E., Webster, J. P., Domingo, E., Charlesworth, B. & Levin, B. R. Biological and biomedical implications of the co evolution of pathogens and their hosts. Nat. Genet. 32, 569-577 (2002).
121. Lipinska, U. et al. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 6, e22864 (2011).
122. Cribier, B., Piemont, Y. & Grosshans, E. Staphylococcal scalded skin syndrome in adults. A clinical review illustrated with a new case. J. Am. Acad. Dermatol. 30, 319-324 (1994).
123. Cremieux, A. C. et al. Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS ONE 4, e7204 (2009).
124. Diep, B. A. et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc. Natl Acad. Sci. USA 107, 5587-5592 (2010).
125. Diep, B. A. et al. Contribution of Panton-Valentine leukocidin in community associated methicillin resistant Staphylococcus aureus pathogenesis. PLoS ONE 3, e3198 (2008).
126. Vancraeynest, D. et al. International dissemination of a high virulence rabbit Staphylococcus aureus clone. J. Vet. Med. B Infect. Dis. Vet. Public Health 53, 418-422 (2006).